MTNB(Matinas BioPharma Holdings, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2019-12-31 | FY 截至 2020-12-31 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $89.81K | $158.33K | $33.00K | $3.19M | $1.10M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$18.92M | −$24.21M | −$24.73M | −$24.59M | −$23.77M |
| 净利润 | −$17.37M | −$22.45M | −$23.28M | −$21.00M | −$22.94M |
| 经营现金流 | −$14.09M | −$17.37M | −$15.22M | −$19.16M | −$15.28M |
| 自由现金流 | −$14.50M | −$17.37M | −$15.48M | −$20.05M | −$15.50M |
| 摊薄每股收益 | $-97.50 | $-90.00 | $-82.50 | $-75.00 | $-79.20 |